Reduction of BCR-ABL Transcript Levels at 6, 12, and 18 Months (mo) Correlates with Long-Term Outcomes on Imatinib (IM) at 72 Mo: An Analysis from the International Randomized Study of Interferon versus STI571 (IRIS) in Patients (pts) with Chronic Phase Chronic Myeloid Leukemia (CML-CP)

Dr Michelle Muller; Professor Stephen O'Brien

Reduction of BCR-ABL Transcript Levels at 6, 12, and 18 Months (mo) Correlates with Long-Term Outcomes on Imatinib (IM) at 72 Mo: An Analysis from the International Randomized Study of Interferon versus STI571 (IRIS) in Patients (pts) with Chronic Phase Chronic Myeloid Leukemia (CML-CP) Lookup NU author(s) Dr Michelle Muller Professor Stephen O'Brien



Author(s)		Hughes TP, Hochhaus A, Branford S, Muller MC, Foroni L, Druker BJ, Guilhot F, Larson RA, O'Brien SG, Waltzman RJ, Mone M, Wehrle E, Radich JP, Goldman JM
Editor(s)
Publication type		Conference Proceedings (inc. Abstract)
Conference Name		Blood: 50th Annual Meeting of the American Society of Hematology
Conference Location		San Francisco, California
Year of Conference		2008
Date		6-9 December 2008
Volume		112, 11
Pages		129-130 no. 334
		0006-4971
ISBN		15280020




Full text for this publication is not currently held within this repository. Alternative links are provided below where available.



Publisher		American Society of Hematology
URL		http://abstracts.hematologylibrary.org/cgi/content/abstract/112/11/334

Actions
Library holdings		Search Newcastle University Library for this item